Chapel Hill CRS (Site #3201)

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• HIV3 trials

Phase

• Phase 23 trials

Status

• Active, not recruiting1 trial
• Completed1 trial
• Not yet recruiting1 trial

Lead sponsor

• National Institute of Allergy and Infectious Diseases (NIAID)3 trials

Running trials

• Not yet recruiting

  A Clinical Study of Ixazomib to Reactivate HIV and Reduce HIV Reservoir Size

  NCT07881809· Phase 2· National Institute of Allergy and Infectious Diseases (NIAID)· Source

  Contact: David Wohl

• Active, not recruiting

  A Study of VRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal Antibodies Given Intravenously in Adult Participants Without HIV

  NCT06812494· Phase 2· National Institute of Allergy and Infectious Diseases (NIAID)· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• HIV1 recruiting

Closed trials

• Completed

  A Study to Evaluate the Effects of Cenicriviroc Mesylate on Arterial Inflammation in People Living With HIV

  NCT05630885· Phase 2· National Institute of Allergy and Infectious Diseases (NIAID)· Source